8-K: Xenon Pharmaceuticals Announces 2024 Annual Shareholder Meeting Details

Xenon Pharmaceuticals has set the date for its 2024 annual shareholder meeting for June 4, 2024, with a record date of April 5, 2024.

Summary

• Xenon Pharmaceuticals Inc. has announced the details for its 2024 annual meeting of shareholders.
• The annual meeting is scheduled for June 4, 2024.
• The record date for notice, voting, and beneficial ownership determination is April 5, 2024.
• Only common shares are entitled to notice and voting at the meeting.
• The company will not be mailing directly to non-objecting beneficial owners.
• Xenon will pay for the material distribution to objecting beneficial owners.
• The company will not be using notice-and-access for registered or non-registered investors.

Sentiment

Score: 7

Explanation: The document is a routine announcement of the annual meeting details, which is neutral to slightly positive as it provides necessary information to shareholders.

Positives

• The company has clearly communicated the key dates for its annual shareholder meeting.
• Xenon will cover the costs of distributing materials to objecting beneficial owners, which is a positive for those shareholders.

Industry Context

This announcement is a routine part of corporate governance for publicly traded companies, ensuring shareholders are informed about the annual meeting and their voting rights.

Comparison to Industry Standards

• The setting of record dates and meeting dates is standard practice for publicly traded companies.
• The decision to pay for objecting beneficial owner material distribution is common, ensuring all shareholders have access to meeting information.
• The use of notice-and-access is optional, and Xenon's decision not to use it is within industry norms.

Stakeholder Impact

• Shareholders are directly impacted by this announcement as it provides details about the annual meeting and their voting rights.
• The announcement ensures transparency and allows shareholders to participate in corporate governance.

Next Steps

• Shareholders should note the record date of April 5, 2024, to ensure they are eligible to vote at the annual meeting.
• Shareholders should expect to receive meeting materials in advance of the June 4, 2024 meeting.

Key Dates

Keywords

Annual Meeting, Shareholders, Record Date, Voting, Common Shares, Xenon Pharmaceuticals